Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-06-04T19:35:19.377Z Has data issue: false hasContentIssue false
  • English
  • Français

Tegretol

Published online by Cambridge University Press:  18 September 2015

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Other
Information
Canadian Journal of Neurological Sciences , Volume 24 , Issue 4 , November 1997 , pp. A-46 - A-47
Copyright
Copyright © Canadian Neurological Sciences Federation 1997

References

References:

1.Ignatowicz, L, Ignatowicz, R, Jozwiak, Ret al. Psychiatric aspects of epilepsy in childhood treated with Tegretol CR (Ciba-Geigy) (Abstr. of paper). Epilepsia (USA) 1995;36(3):S128–S129.Google Scholar
2.De deyn Peter, Mol L, et al. An open multicenter prospective study of the effects of monotherapy with controlled-release carbamazepine on newly diagnosed generalized tonic&-clonic seizures. Seizure 1994;3:235–238.CrossRefGoogle Scholar
3.Eeg-Olofsson, O, Nilsson, H, Tonnby, B, et al. Diurnal variation of carbamazepine and carbamazepine-10,11- epoxide in plasma and saliva in children with epilepsy: A comparison between conventional and slow-release formulations. Jrnl Child Neurol (USA) 1990;5(2):159–165.CrossRefGoogle ScholarPubMed
4.Tegretol® Product Monograph, November 1995.Google Scholar
5.Aldenkamp, et al. Controlled release carbamazepine: cognitive side effects in patients with epilepsy. Epilepsia 1987;28(3):507–514.CrossRefGoogle ScholarPubMed
6.Dhalla, Z, Bruni, J, Sutton, J. A comparison of the efficacy and tolerability of controlled-release carbamazepine. Cdn Jrnl Neurl Sciences 1991;18:66–68.Google ScholarPubMed
7.Canger, R, Altamura, AC, Belvedere, O, Monaco, F, Monza, GCet al. Conventional vs controlled-release carbamazepine: a multicentre, double-blind, cross-over study. Acta Neurol Scand 1990;82:9–13.CrossRefGoogle ScholarPubMed